blister has been researched along with Neoplasms* in 4 studies
1 review(s) available for blister and Neoplasms
Article | Year |
---|---|
Targeting Myosin by Blebbistatin Derivatives: Optimization and Pharmacological Potential.
Blebbistatin is a widely used inhibitor of myosin 2 that enables the study of a broad range of cytoskeleton-related processes. However, blebbistatin has several limitations hindering its applicability: it is fluorescent, poorly water soluble, cytotoxic, and prone to (photo)degradation. Despite these adverse effects, being the only available myosin 2-specific inhibitor, blebbistatin is rather a choice of necessity. Blebbistatin has been modified to improve its properties and some of the new compounds have proven to be useful replacements of the original molecule. This review summarizes recent results on blebbistatin development. We also discuss the pharmacological perspectives of these efforts, as myosins are becoming promising drug target candidates for a variety of conditions ranging from neurodegeneration to muscle disease, wound healing, and cancer metastasis. Topics: Animals; Drug Delivery Systems; Heterocyclic Compounds, 4 or More Rings; Humans; Muscular Diseases; Myosins; Neoplasm Metastasis; Neoplasms; Neurodegenerative Diseases; Wound Healing | 2018 |
3 other study(ies) available for blister and Neoplasms
Article | Year |
---|---|
Oxygen-Independent Photocleavage of Radical Nanogenerator for Near-IR-Gated and H
The oxygen-dependent nature and limited penetration capacity of visible light render the low efficiency of photodynamic therapy in hypoxic and deep-seated tumors. Therefore, the development of oxygen-free photoactivated chemotherapy (PACT) to generate cytotoxic reactive oxygen species by near-IR (NIR) light-cleavable photocages is in high demand. Here, an oxygen-irrelevant PACT strategy based on NIR light-triggered hydroxyl radicals (•OH) generation is developed for free-radical nanotherapy. Blebbistatin-loaded upconversion of mesoporous silica nanoparticles (UCSNs-B) is established to facilitate the high loading efficiency of blebbistatin and implement the efficient transformation of NIR light into blue light for unprecedented direct photorelease of oxygen-independent •OH. Under NIR laser irradiation, UCSNs-B converted NIR light into blue light, thus enabling the photocleavage of blebbistatin to induce the burst of •OH. The •OH burst under NIR laser irradiation further induces cancer cell apoptosis and significant suppression of hypoxic tumors. In addition, the gadolinium ion (Gd Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Free Radicals; Gadolinium; Heterocyclic Compounds, 4 or More Rings; Humans; Infrared Rays; Magnetic Resonance Imaging; Mice; Nanomedicine; Nanoparticles; Neoplasms; Neoplasms, Experimental; Oxygen; Photochemotherapy; Reactive Oxygen Species; Silicon Dioxide | 2021 |
Tumour cell blebbing and extracellular vesicle shedding: key role of matrikines and ribosomal protein SA.
Carcinogenesis occurs in elastin-rich tissues and leads to local inflammation and elastolytic proteinase release. This contributes to bioactive matrix fragment (Matrikine) accumulation like elastin degradation products (EDP) stimulating tumour cell invasive and metastatic properties. We previously demonstrate that EDPs exert protumoural activities through Hsp90 secretion to stabilised extracellular proteinases.. EDP influence on cancer cell blebbing and extracellular vesicle shedding were examined with a videomicroscope coupled with confocal Yokogawa spinning disk, by transmission electron microscopy, scanning electron microscopy and confocal microscopy. The ribosomal protein SA (RPSA) elastin receptor was identified after affinity chromatography by western blotting and cell immunolocalisation. mRNA expression was studied using real-time PCR. SiRNA were used to confirm the essential role of RPSA.. We demonstrate that extracellular matrix degradation products like EDPs induce tumour amoeboid phenotype with cell membrane blebbing and shedding of extracellular vesicle containing Hsp90 and proteinases in the extracellular space. EDPs influence intracellular calcium influx and cytoskeleton reorganisation. Among matrikines, VGVAPG and AGVPGLGVG peptides reproduced EDP effects through RPSA binding.. Our data suggests that matrikines induce cancer cell blebbing and extracellular vesicle release through RPSA binding, favouring dissemination, cell-to-cell communication and growth of cancer cells in metastatic sites. Topics: Amides; Calcium; Cell Communication; Cell Line, Tumor; Elastin; Extracellular Matrix Proteins; Extracellular Vesicles; Heterocyclic Compounds, 4 or More Rings; HSP90 Heat-Shock Proteins; Humans; Neoplasms; Peptide Fragments; Pyridines; Receptors, Laminin; rho-Associated Kinases; Ribosomal Proteins; Signal Transduction | 2019 |
HuR translocation to the cytoplasm of cancer cells in actin-independent manner.
Human antigen R (HuR) is a RNA-binding protein, which binds to the AU-rich element (ARE) in the 3'-untranslated region (3'-UTR) of certain mRNA and is involved in the export and stabilization of ARE-mRNA. HuR constitutively relocates to the cytoplasm in many cancer cells, however the mechanism of intracellular HuR trafficking is poorly understood. To address this question, we examined the functional role of the cytoskeleton in HuR relocalization. We tested the effect of actin depolymerizing macrolide latrunculin A or myosin II ATPase activity inhibitor blebbistatin for HuR relocalization induced by the vasoactive hormone Angiotensin II in cancer and control normal cells. Western blot and confocal imaging data revealed that both inhibitors attenuated the cytoplasmic HuR in normal cells but no such alteration was observed in cancer cells. Concomitant with changes in intracellular HuR localization, both inhibitors markedly decreased the accumulation and half-lives of HuR target ARE-mRNAs in normal cells, whereas no change was observed in cancer cells. Furthermore, co-immunoprecipitation experiments with HuR proteins revealed clear physical interaction with ß-actin only in normal cells. The current study is the first to verify that cancer cells can implicate a microfilament independent HuR transport. We hypothesized that when cytoskeleton structure is impaired, cancer cells can acquire an alternative HuR trafficking strategy. Topics: 3' Untranslated Regions; Actins; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cytoplasm; Cytoskeleton; ELAV-Like Protein 1; HeLa Cells; Hep G2 Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Myosins; Neoplasms; Protein Binding; Protein Transport; RNA Stability; RNA, Messenger; Thiazolidines | 2018 |